179 related articles for article (PubMed ID: 4048971)
21. [Intraperitoneal cisplatin chemotherapy for ovarian cancer].
Hayashi H; Nishii H; Ueda K; Kunitou S; Wada S; Takanashi H; Kobayashi S; Yasuda M
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2043-8. PubMed ID: 11791382
[TBL] [Abstract][Full Text] [Related]
22. Intraperitoneal chemotherapy: a reemerging approach in the treatment of ovarian cancer.
Drake B
J Infus Nurs; 2009; 32(6):314-22. PubMed ID: 19918140
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal chemotherapy in ovarian cancer.
Hofstra LS; de Vries EG; Mulder NH; Willemse PH
Cancer Treat Rev; 2000 Apr; 26(2):133-43. PubMed ID: 10772970
[TBL] [Abstract][Full Text] [Related]
24. Intraperitoneal chemotherapy in the management of malignant disease.
Markman M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
[TBL] [Abstract][Full Text] [Related]
25. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
Malmström H; Carstensen J; Simonsen E
Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835
[TBL] [Abstract][Full Text] [Related]
26. Intraperitoneal chemotherapy in the management of ovarian cancer.
Ozols R
Semin Oncol; 1985 Sep; 12(3 Suppl 4):75-80. PubMed ID: 4048980
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
Panteix G; Beaujard A; Garbit F; Chaduiron-Faye C; Guillaumont M; Gilly F; Baltassat P; Bressolle F
Anticancer Res; 2002; 22(2B):1329-36. PubMed ID: 12168946
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of complications associated with catheter intraperitoneal chemotherapy of ovarian carcinoma].
Wei LH; Qian HN; Li WF
Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):732-4, 762-3. PubMed ID: 7712902
[TBL] [Abstract][Full Text] [Related]
29. [Safety and efficacy of hypotonic CDDP intraperitoneal administration for gastric cancer with peritoneal dissemination].
Bamba T; Kanda T; Ohashi M; Hanyu T; Sakamoto K; Ishikawa T; Yajima K; Makino S; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1695-7. PubMed ID: 16315912
[TBL] [Abstract][Full Text] [Related]
30. Peritoneal cytology of ovarian cancer patients receiving intraperitoneal therapy: quantitation of malignant cells and response.
Sagae S; Berek JS; Fu YS; Chang N; Dauplat J; Hacker NF
Obstet Gynecol; 1988 Nov; 72(5):782-8. PubMed ID: 3173930
[TBL] [Abstract][Full Text] [Related]
31. The use of intraperitoneal chemotherapy in the treatment of ovarian cancer.
Myers C
Semin Oncol; 1984 Sep; 11(3):275-84. PubMed ID: 6385257
[No Abstract] [Full Text] [Related]
32. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
33. Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer.
Meunier F; van der Auwera P; Aoun M; Piccart M; Sculier JP
Scand J Infect Dis Suppl; 1990; 72():26-8. PubMed ID: 2151063
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
Deng C; Huang R; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial.
Braly PS; Berek JS; Blessing JA; Homesley HD; Averette H
Gynecol Oncol; 1995 Feb; 56(2):164-8. PubMed ID: 7896179
[TBL] [Abstract][Full Text] [Related]
36. Distribution of intraperitoneal chemotherapy into the pleural cavity.
Vaccarello L; Berghella V; Rubin SC; Hoskins WJ
Obstet Gynecol; 1994 Oct; 84(4 Pt 2):714-7. PubMed ID: 9205461
[TBL] [Abstract][Full Text] [Related]
37. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
[TBL] [Abstract][Full Text] [Related]
38. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
[TBL] [Abstract][Full Text] [Related]
39. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
Almadrones L
Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
[TBL] [Abstract][Full Text] [Related]
40. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]